JPH0371901B2 - - Google Patents
Info
- Publication number
- JPH0371901B2 JPH0371901B2 JP25559087A JP25559087A JPH0371901B2 JP H0371901 B2 JPH0371901 B2 JP H0371901B2 JP 25559087 A JP25559087 A JP 25559087A JP 25559087 A JP25559087 A JP 25559087A JP H0371901 B2 JPH0371901 B2 JP H0371901B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- release sheet
- pad
- blister
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 claims description 44
- 229940079593 drug Drugs 0.000 claims description 40
- 239000011248 coating agent Substances 0.000 claims description 16
- 238000000576 coating method Methods 0.000 claims description 16
- 239000000853 adhesive Substances 0.000 claims description 13
- 230000001070 adhesive effect Effects 0.000 claims description 13
- 206010052428 Wound Diseases 0.000 description 15
- 208000027418 Wounds and injury Diseases 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- SIACJRVYIPXFKS-UHFFFAOYSA-N (4-sulfamoylphenyl)methylazanium;chloride Chemical compound Cl.NCC1=CC=C(S(N)(=O)=O)C=C1 SIACJRVYIPXFKS-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- OJFZXRZZXBFEAP-UHFFFAOYSA-N 5-chloro-1,6-dimethylcyclohexa-2,4-dien-1-ol Chemical compound ClC=1C(C(C=CC1)(C)O)C OJFZXRZZXBFEAP-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960002645 boric acid Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003290 cortisone acetate Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960002800 prednisolone acetate Drugs 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
- 229960001975 sulfisomidine Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
【発明の詳細な説明】
一般に繁用の簡易救急絆創膏は、殺菌消毒剤、
創傷治療剤を含浸させたガーゼを通気孔を有する
粘着性のシートに装着し、使用時に裏面の剥離紙
をはがして前記ガーゼ部を傷口局所に当てて使用
するようにしたものである。[Detailed Description of the Invention] Commonly used simple emergency bandages include sterilizing and disinfecting agents,
Gauze impregnated with a wound treatment agent is attached to an adhesive sheet with ventilation holes, and when used, the release paper on the back is peeled off and the gauze section is applied to the wound.
しかしながら、これらの従来品においては、予
めガーゼに薬液を含浸させておくため、経時的に
薬液が蒸散し、また効力の失活をきたすばかりで
なく、局所への当接に際してはガーゼ部が乾燥状
態となつているため、傷口をいためるおそれがあ
り、使用に際しても、痛みを感じさせる等の欠点
があつた。 However, in these conventional products, since the gauze is impregnated with the drug solution in advance, the drug solution evaporates over time and not only loses its effectiveness, but also causes the gauze part to dry when applied to the local area. Because of this condition, there was a risk of damaging the wound, and there were drawbacks such as making people feel pain when using it.
また、薬剤被覆膜により薬剤をシールしたブリ
スター部を有する救急絆創膏であつて、使用に際
してブリスター部を指で押圧して薬剤被覆膜を破
壊することにより薬剤をパツドに含浸させるもの
も知られている（実公昭54−23197号公報、米国
特許第3297032号明細書）。 Furthermore, there are also known emergency bandages that have a blister portion with a drug-coated film sealed in it, and in which the drug is impregnated into the pad by pressing the blister part with your finger to break the drug-covering film during use. (Utility Model Publication No. 54-23197, US Pat. No. 3,297,032).
しかしながら、この型の救急絆創膏は、ブリス
ター部が平滑な表面を有するものであるため、こ
れを押圧した時、力がブリスター部全体に分散
し、押圧部全体が不規則に窪んでしまうため、ブ
リスター部が薬剤被覆膜に到達してこれを破壊す
ることは非常に困難であつた。 However, since the blister part of this type of emergency bandage has a smooth surface, when the blister part is pressed, the force is dispersed over the entire blister part, causing the entire pressing part to become irregularly depressed. It was very difficult for the drug to reach and destroy the drug-coated film.
また、例えばブリスター部の内部圧力の上昇に
よつて薬剤被覆膜が破壊された場合でも、破壊箇
所はブリスター部と薬剤被覆膜の接線部分とな
り、薬剤がパツド外縁部又はパツド外に移動し、
その効果が損なわれるという問題があつた。 Furthermore, even if the drug coating film is destroyed due to an increase in the internal pressure of the blister part, the breakage point will be a tangent between the blister part and the drug coating film, and the drug will not move to the outer edge of the pad or outside the pad. ,
There was a problem that the effect was lost.
また、米国特許第4117841号明細書には接着剤
が塗布された絆創膏ストリツプの中央部下表面
に、薬剤を保持する空間を形成して液体不浸透性
のシート（或いは液体不浸透性層を介して液体浸
透性のシート）を設け、該空間内の絆創膏ストリ
ツプの下表面にプラスチツクの歯のような突起体
を設け、また該空間内に薬剤を充填した絆創膏に
ついて記載されている。 In addition, US Pat. No. 4,117,841 discloses that a space for holding a drug is formed on the central lower surface of an adhesive-coated adhesive bandage strip, and a liquid-impermeable sheet (or a liquid-impermeable layer is used) to form a space for holding a drug. A bandage is described in which a liquid-permeable sheet is provided, plastic tooth-like protrusions are provided on the lower surface of the bandage strip in the space, and a drug is filled in the space.
この絆創膏は、使用に際し、前記シートを突起
体に指により押しつけ、シートを破壊して薬剤を
傷口に直接垂らした後、絆創膏を傷口に適用する
ものであるが、指によりシートを突起体に押しつ
けシートを破壊する操作は、突起体の先鋭部分に
より指を痛め、または傷つける恐れがあり、また
シートの破壊時に一部の薬液が指に付着し、更に
その後薬液を傷口に垂らす際に一部の薬液が傷口
から滴り落ちて薬液が無駄になる。また、この絆
創膏の基本的欠点として、絆創膏は突起体が残存
したまま、かつ、その先鋭部分が傷口に向つた状
態で傷口に適用されるので、突起体により傷をい
つそう傷める危険性があり、そうでなくても使用
感が極めて悪いという欠点を有するものである。 When using this bandage, the sheet is pressed against the protrusion with a finger, the sheet is broken and the medicine is dripped directly onto the wound, and then the bandage is applied to the wound. The operation of destroying the sheet may injure or injure the fingers due to the sharp parts of the protrusions, and some of the chemical may adhere to the fingers when the sheet is destroyed, and furthermore, some of the chemical may adhere to the fingers when dripping the chemical onto the wound. The drug solution drips from the wound and is wasted. In addition, a basic drawback of this bandage is that it is applied to the wound with the protrusions remaining and the sharp edges facing the wound, so there is a risk that the protrusions may damage the wound at any time. However, even if this is not the case, it has the disadvantage of being extremely uncomfortable to use.
本発明は上記した従来技術の欠点を解決したも
のである。 The present invention solves the above-mentioned drawbacks of the prior art.
即ち、本発明の救急絆創膏は、パツドを装着し
た粘着シートと剥離シートとからなり、該剥離シ
ートには、薬剤被覆膜によりその下面がシールさ
れ、かつ薬剤を内包するブリスター部が前記パツ
ド上に位置して設けられており、剥離シートのブ
リスター部の両サイドには、剥離シートの巾方向
に向けてミシン目が設けられていることを特徴と
する。 That is, the emergency bandage of the present invention consists of an adhesive sheet on which a pad is attached and a release sheet, the release sheet has a lower surface sealed with a drug coating film, and a blister portion containing a drug is placed on the pad. It is characterized in that perforations are provided on both sides of the blister portion of the release sheet in the width direction of the release sheet.
本発明の救急絆創膏は、剥離シートのブリスタ
ー部の両サイドに剥離シートの巾方向に向けてミ
シン目が設けられているため、使用に際して該ミ
シン目に沿つて剥離シートを折り曲げることによ
り、若しくは、ブリスター部を指で押圧すること
により、薬剤被覆膜は、無理なく破壊され、薬剤
はパツドに無駄なく確実に移動する。 The emergency bandage of the present invention has perforations on both sides of the blister part of the release sheet in the width direction of the release sheet, so when in use, the release sheet can be folded along the perforations or By pressing the blister portion with a finger, the drug coating membrane is easily destroyed and the drug is transferred to the pad without wastage.
このようにして、薬剤をパツドに移動させた
後、薬剤被覆膜およびブリスター部を有する剥離
シートは粘着シートから除去される。そして傷口
には薬剤の付いたパツドを有する粘着シートのみ
が適用されるので使用上の危険性や違和感がな
い。 After the drug is transferred to the pad in this manner, the release sheet having the drug coating film and the blister portion is removed from the adhesive sheet. Since only the adhesive sheet having the pad with the drug applied to the wound is applied, there is no danger or discomfort during use.
本発明に使用する薬剤については、殺菌消毒剤
としてグルコン酸クロルヘキシジン、塩化ベンザ
ルコニウム、クロルキシレノール、アクリノー
ル、チアントール、塩化デカリニウム、スルフイ
ソミジン、スルフアミン、ニトロフラゾン、ホウ
酸、ホモスルフアミン、トリクロカルバン等があ
り、創傷部収斂治癒促進剤として酸化亜鉛、塩酸
ピリドキシン、酢酸トコフエロール、ジバルミチ
ン酸ピリドキシン等、止血剤としては塩酸ナフア
ゾリン、硫酸亜鉛、塩酸エフエドリン等、抗炎症
剤としてはプレドニゾロン、デキサメサゾン、酢
酸コルチゾン等のステロイド剤、グリチルレチ
ン、塩化リゾチーム等、抗ヒスタミン剤としてマ
レイン酸クロルフエニラミン、塩酸ジフエンヒド
ラミン等がある。 The agents used in the present invention include chlorhexidine gluconate, benzalkonium chloride, chlorxylenol, acrinol, thianthol, dequalinium chloride, sulfisomidine, sulfamine, nitrofurazone, boric acid, homosulfamine, triclocarban, etc. Astringent healing promoters include zinc oxide, pyridoxine hydrochloride, tocopherol acetate, pyridoxine divalmitate, etc. Hemostatic agents include napazoline hydrochloride, zinc sulfate, and ephedrine hydrochloride; anti-inflammatory agents include steroids such as prednisolone, dexamethasone, and cortisone acetate; Antihistamines such as glycyrrhetin and lysozyme chloride include chlorpheniramine maleate and diphenhydramine hydrochloride.
又、局麻剤としてはリドカイン、アミノ安息香
酸エチル、塩酸プロカイン、塩酸ジプカイン、塩
酸テトラカイン、塩酸パラブチルアミノ安息香酸
ジエチルアミノエチル等がある。 Local narcotics include lidocaine, ethyl aminobenzoate, procaine hydrochloride, dypcaine hydrochloride, tetracaine hydrochloride, diethylaminoethyl parabutylaminobenzoate hydrochloride, and the like.
これらの薬剤は目的に合わせ、単味で又は複数
の配合剤とすることができ、又、薬剤の性状は溶
液状の他、軟膏状、グリース状、粉末等流動性の
あるものであれば以下なる性状でもよい。 Depending on the purpose, these drugs can be used singly or in combination, and the properties of the drugs are as follows, as long as they are fluid, such as solution, ointment, grease, and powder. It may have the following properties.
粘着シートは、通常用いられるものでもよく、
パツドは、脱脂綿その他各種の綿、不織布等を使
用することができ、適宜その中央部をへこませた
形状とすることができる。又、通常の方法により
裏面を防水処理してもよい。 The adhesive sheet may be one commonly used,
The pad can be made of absorbent cotton, various types of cotton, non-woven fabric, etc., and can be appropriately shaped with a concave central portion. Further, the back surface may be waterproofed by a conventional method.
剥離シートは、塩化ビニール樹脂その他の合成
樹脂等の材質により成型され、中央部に円形、だ
円形若しくは矩形状のブリスター部を設け、又剥
離シートをめくり易くするために端部にスリツト
を設けるのがよい。 The release sheet is molded from a material such as vinyl chloride resin or other synthetic resin, and has a circular, oval, or rectangular blister section in the center, and slits at the ends to make it easier to turn over the release sheet. Good.
剥離シートのブリスター部下面には、薬剤を使
用時までパツドに接触させるのを防止するための
薬剤被覆膜がシールしてある。薬剤被覆膜はアル
ミ箔、グラシン紙等の破壊されやすい膜が採用さ
れる。該被覆膜は、薬剤を保護しうる大きさでよ
いが、剥離シートの下面全体に設けられていても
さしつかえない。 A drug coating film is sealed on the lower surface of the blister of the release sheet to prevent the drug from coming into contact with the pad until use. As the drug coating membrane, a membrane that is easily destroyed, such as aluminum foil or glassine paper, is used. The coating film may be large enough to protect the drug, but may be provided on the entire lower surface of the release sheet.
以下、図面により本発明を更に詳細に説明す
る。第１図は本発明の救急絆創膏の一実施例の断
面図、第２図は第１図のＡ−A′縦断面図、第３
図は剥離シートの平面図である。 Hereinafter, the present invention will be explained in more detail with reference to the drawings. FIG. 1 is a sectional view of one embodiment of the emergency bandage of the present invention, FIG. 2 is a longitudinal sectional view taken along line A-A' in FIG.
The figure is a plan view of a release sheet.
図面において、１はパツド２を装着した粘着シ
ートであり、パツド上部には薬剤３が、薬剤被覆
膜５と剥離シート４に設けられたブリスター部６
との間の空間内に内包されている。そして、剥離
シートのブリスター部の両サイドには、剥離シー
トの巾方向に向けてミシン目８が設けられてい
る。また剥離シート４の端部にはスリツト７が刻
設してある。救急絆創膏を使用するに際しては、
ミシン目８に沿つて剥離シートを折り曲げるか、
或いはブリスター部を指で押圧して薬剤被覆膜５
を破壊することにより薬剤３をパツド２上に移動
させる。 In the drawing, reference numeral 1 denotes an adhesive sheet with a pad 2 attached thereon, a drug 3 is placed on the top of the pad, and a blister portion 6 provided on a drug coating film 5 and a release sheet 4 is placed on the top of the pad.
It is contained within the space between. Perforations 8 are provided on both sides of the blister portion of the release sheet in the width direction of the release sheet. Furthermore, a slit 7 is cut into the end of the release sheet 4. When using emergency bandages,
Fold the release sheet along perforation 8, or
Alternatively, press the blister part with your finger to remove the drug coating film 5.
The medicine 3 is moved onto the pad 2 by destroying it.
次いで、スリツト７を折り曲げ剥離シート４を
粘着シートよりはがし、新鮮な薬剤の付いたパツ
ド２の部分を創傷面に当接使用する。 Next, the slit 7 is bent, the release sheet 4 is peeled off from the adhesive sheet, and the part of the pad 2 with fresh medicine applied is brought into contact with the wound surface.
また、本発明の救急絆創膏に於ては、第４図に
示すように、ブリスター部６の凹状の突起９を設
けることができる。このようにブリスター部に凹
状の突起を設けておくと、該凹状の突起の窪み部
分に指をかけて押圧することができるのでブリス
ター部の押圧操作がしやすく、そして突起部分は
形状的にその周辺部分より硬いため、これを上方
より押圧すれば突起部分は、その形状が壊れるこ
となく、薬剤被覆膜に到達し、その所望の場所、
一般的にはパツドの中央部に対応する箇所の薬剤
被覆膜を破壊するので薬剤のパツドへの移動をよ
り確実に行うことができる。 Further, in the emergency bandage of the present invention, a concave projection 9 of the blister portion 6 can be provided as shown in FIG. By providing a concave protrusion in the blister part in this way, it is possible to press the blister part by placing a finger on the recessed part of the concave protrusion, making it easier to press the blister part. Since the protruding part is harder than the surrounding part, if it is pressed from above, the protruding part will reach the drug coating film without breaking its shape and reach the desired location.
Generally, since the drug coating film in the area corresponding to the center of the pad is destroyed, the transfer of the drug to the pad can be carried out more reliably.
本発明の効果は次のとおりである。 The effects of the present invention are as follows.
本発明の救急絆創膏は、剥離シートのブリスタ
ー部の両サイドに剥離シートの巾方向に向けてミ
シン目が設けられているため、使用に際して該ミ
シン目に沿つて剥離シートを折り曲げることによ
り、若しくはブリスター部を指で押圧することに
より薬剤被覆膜は容易に、かつ確実に破壊され
る。そして、薬剤はパツドに無駄なく、確実に移
動する。また、薬剤をパツドに移動させた後、薬
剤被覆膜およびブリスター部を有する剥離シート
は粘着シートから除去され、傷口には新鮮な薬剤
が付いたパツドを有する粘着シートのみが適用さ
れ、米国特許第411841号明細書の絆創膏のように
突起体のような不要物が傷口部分に当接されるこ
とがないので傷口に対して違和感がなく、かつ安
全に使用することができ、殺菌、消毒、治療の所
望の目的を有効に達成できるものである。 The emergency bandage of the present invention is provided with perforations in the width direction of the release sheet on both sides of the blister portion of the release sheet, so when in use, the release sheet can be folded along the perforations or the blister By pressing the part with a finger, the drug coating film is easily and reliably destroyed. The medicine is then transferred reliably to the pad without any waste. In addition, after the drug is transferred to the pad, the release sheet with the drug coating film and the blister part is removed from the adhesive sheet, and only the adhesive sheet with the pad with fresh drug is applied to the wound. Unlike the bandage in Specification No. 411841, unnecessary objects such as protrusions are not brought into contact with the wound, so there is no discomfort to the wound, and it can be used safely. The desired objectives of treatment can be effectively achieved.
第１図は、本発明の救急絆創膏の平面図、第２
図は、第１図のＡ−A′縦断面図、第３図は、第
１図の救急絆創膏の剥離シートの平面図、第４図
は、他の実施例における剥離シートの斜視図。
１……粘着シート、２……パツド、３……薬
剤、４……剥離シート、５……薬剤被覆膜、６…
…ブリスター部、７……スリツト、８……ミシン
目、９……凹状突起。
FIG. 1 is a plan view of the emergency bandage of the present invention, and FIG.
3 is a plan view of the release sheet of the emergency bandage shown in FIG. 1, and FIG. 4 is a perspective view of the release sheet in another embodiment. DESCRIPTION OF SYMBOLS 1... Adhesive sheet, 2... Pad, 3... Drug, 4... Peeling sheet, 5... Drug coating film, 6...
...Blister portion, 7...Slit, 8...Perforation, 9...Concave projection.
Claims (1)
からなり、該剥離シートには、薬剤被覆膜により
その下面がシールされ、かつ薬剤を内包するブリ
スター部が前記パツド上に位置して設けられてお
り、剥離シートのブリスター部の両サイドには、
剥離シートの巾方向に向けてミシン目が設けられ
ていることを特徴とする救急絆創膏。1 Consisting of an adhesive sheet with a pad attached and a release sheet, the release sheet has a lower surface sealed with a drug coating film, and a blister portion containing the drug is provided on the pad. , on both sides of the blister part of the release sheet,
An emergency bandage characterized by having perforations in the width direction of the release sheet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25559087A JPS63119764A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25559087A JPS63119764A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP41048790A Division JPH03247335A (en) | 1990-12-13 | 1990-12-13 | Emergency adhesive bandage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63119764A JPS63119764A (en) | 1988-05-24 |
| JPH0371901B2 true JPH0371901B2 (en) | 1991-11-14 |
Family
ID=17280837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25559087A Granted JPS63119764A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63119764A (en) |
-
1987
- 1987-10-09 JP JP25559087A patent/JPS63119764A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63119764A (en) | 1988-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880003941Y1 (en) | First aid adhesive tape | |
| US6120792A (en) | Medicated skin patch and method for its use | |
| US8911773B2 (en) | Peelable pouch for transdermal patch and method for packaging | |
| US2579403A (en) | Medical bandage | |
| JP2513712B2 (en) | Wound dressing | |
| US4134399A (en) | Skin protective device | |
| US3366112A (en) | Adhesive bandage having container of liquid medicament | |
| US7745683B2 (en) | Deformable and conformable wound protecting apparatus and its method of application | |
| US20040049144A1 (en) | Hypoallergenic bandage | |
| US2340142A (en) | Surgical dressing | |
| US20080039760A1 (en) | Removable gauze bandage with perforated adhesive strips to adjust bandage | |
| JPH07308339A (en) | Aseptic wound packing | |
| JPH0157580B2 (en) | ||
| JPH0371901B2 (en) | ||
| JPH0371900B2 (en) | ||
| JP4136182B2 (en) | Emergency bandage | |
| JPH04329951A (en) | Bandage for emergency | |
| JPH03247335A (en) | Emergency adhesive bandage | |
| JPH0534649Y2 (en) | ||
| KR880003940Y1 (en) | First Aid Band-Aid | |
| JPH0432099Y2 (en) | ||
| JPS61222451A (en) | Emergency bandage | |
| JPH0856982A (en) | Adhesive tape | |
| JPS6220191Y2 (en) | ||
| JPH038260Y2 (en) |